文献速递脊柱关节炎

新发炎性背痛患者的临床演变:一项基于人群的队列研究

Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study.
PubMed 文献 · Arthritis Rheumatol · 2018-05-13

该回顾性纵向研究利用罗切斯特流行病学项目,在1999至2003年期间识别了124例16-35岁新发炎性背痛患者,随访至2016年7月。中位随访13.2年后,39例进展为脊柱关节炎,58例炎性背痛缓解,10年时进展为脊柱关节炎的概率为30%,缓解概率为43%。葡萄膜炎、男性性别和脊柱关节炎家族史是进展为脊柱关节炎的最重要预测因素。

要点

  • 新发炎性背痛患者中仅少数进展为脊柱关节炎,多数患者炎性背痛可缓解。
  • 10年时进展为脊柱关节炎的概率为30%,炎性背痛缓解的概率为43%。
  • 葡萄膜炎、男性性别和脊柱关节炎家族史是进展为脊柱关节炎的最重要预测因素。

核心结论

  • 少数新发炎性背痛患者进展为脊柱关节炎,而许多患者炎性背痛可缓解。
  • 炎性背痛常可缓解可能解释了炎性背痛患病率(3-6%)与脊柱关节炎患病率(0.4-1.3%)之间的差异。

研究设计与样本

  • 回顾性纵向研究,使用罗切斯特流行病学项目(明尼苏达州奥姆斯特德县居民基于人群的长期队列)。
  • 识别1999至2003年间因背痛就诊的16-35岁患者,筛查新发炎性背痛,并通过病历回顾收集脊柱关节炎的临床、实验室和影像学特征。
  • 随访至2016年7月,采用竞争风险生存分析检查进展至脊柱关节炎、非脊柱关节炎诊断或背痛缓解,并使用递归分区识别进展至脊柱关节炎的预测因素。

主要发现

  • 在5,304例背痛患者中,识别出124例新发炎性背痛患者。
  • 中位随访13.2年后,39例进展为脊柱关节炎,15例出现非脊柱关节炎诊断,58例炎性背痛缓解。
  • 10年时进展为脊柱关节炎的概率为30%,炎性背痛缓解的概率为43%。
  • 进展为脊柱关节炎的最重要预测因素为葡萄膜炎、男性性别和脊柱关节炎家族史。

关键数值与推荐

  • 10年时进展为脊柱关节炎的概率为30%,炎性背痛缓解的概率为43%。
  • 进展为脊柱关节炎的最重要预测因素为葡萄膜炎、男性性别和脊柱关节炎家族史。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inflammatory back pain (IBP) is often an early manifestation of spondyloarthritis (SpA), but the prognosis of patients with incident IBP is unknown. This study was undertaken to investigate long-term outcomes in patients with IBP, and predictors of progression to SpA, in a population-based cohort. METHODS: We conducted a retrospective, longitudinal study using the Rochester Epidemiology Project, a longstanding population-based cohort of residents of Olmsted County, MN. Patients ages 16-35 years with clinical visits for back pain from 1999 to 2003 were identified, and we screened these patients for the presence of new-onset IBP and performed medical record reviews to collect data on clinical, laboratory, and imaging features of SpA. Outcomes in these patients were followed up until July 2016. We used survival analysis for competing risks to examine progression to either SpA, a non-SpA diagnosis, or resolution of back pain. Recursive partitioning was used to identify predictors of progression to SpA. RESULTS: Among 5,304 patients with back pain, we identified 124 patients with new-onset IBP. After a median follow-up of 13.2 years, IBP had progressed to SpA in 39 patients, 15 patients developed a non-SpA diagnosis, and 58 patients had resolution of IBP. At 10 years, the probability of having SpA was 30%, while the probability of resolution of IBP was 43%. The most important predictors for progression to SpA were uveitis, male sex, and family history of SpA. CONCLUSION: In a minority of patients, new-onset IBP progresses to SpA, while IBP resolves in many. That IBP often resolves may explain the difference between the prevalence of IBP (3-6%) and the prevalence of SpA (0.4-1.3%).

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Wang R, Crowson CS, Wright K, et al. Clinical Evolution in Patients With New-Onset Inflammatory Back Pain: A Population-Based Cohort Study. Arthritis Rheumatol. 2018. PMID: 29471593. doi:10.1002/art.40460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。